☰

Michael J. Flister, Ph.D. - Publications

Affiliations: 
2010 Molecular Biology Microbiology and Biochemistry Southern Illinois University at Carbondale, Carbondale, IL 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gerbec ZJ, Hashemi E, Nanbakhsh A, Holzhauer S, Yang C, Mei A, Tsaih SW, Lemke A, Flister MJ, Riese MJ, Thakar MS, Malarkannan S. Conditional Deletion of PGC-1α Results in Energetic and Functional Defects in NK Cells. Iscience. 23: 101454. PMID 32858341 DOI: 10.1016/J.Isci.2020.101454  0.32
2020 Rau A, Manansala R, Flister MJ, Rui H, Jaffrézic F, Laloë D, Auer PL. Individualized multi-omic pathway deviation scores using multiple factor analysis. Biostatistics (Oxford, England). PMID 32766691 DOI: 10.1093/Biostatistics/Kxaa029  0.344
2020 Sharma G, Jagtap JM, Parchur AK, Gogineni VR, Ran S, Bergom C, White SB, Flister MJ, Joshi A. Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy. Theranostics. 10: 5368-5383. PMID 32373218 DOI: 10.7150/Thno.41171  0.599
2020 Schlaak RA, Frei A, Fish BL, Harmann L, Gasperetti T, Pipke JL, Sun Y, Rui H, Flister MJ, Gantner BN, Bergom C. Acquired Immunity Is Not Essential for Radiation-Induced Heart Dysfunction but Exerts a Complex Impact on Injury. Cancers. 12. PMID 32316187 DOI: 10.3390/Cancers12040983  0.34
2020 Schlaak RA, Frei A, SenthilKumar G, Tsaih SW, Wells C, Mishra J, Flister MJ, Camara AKS, Bergom C. Differences in Expression of Mitochondrial Complexes Due to Genetic Variants May Alter Sensitivity to Radiation-Induced Cardiac Dysfunction. Frontiers in Cardiovascular Medicine. 7: 23. PMID 32195269 DOI: 10.3389/Fcvm.2020.00023  0.327
2020 Brandt AC, McNally L, Lorimer EL, Unger B, Koehn OJ, Suazo KF, Rein L, Szabo A, Tsaih SW, Distefano MD, Flister MJ, Rigo F, McNally MT, Williams CL. Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy. Proceedings of the National Academy of Sciences of the United States of America. PMID 32019878 DOI: 10.1073/Pnas.1914153117  0.378
2019 Nanbakhsh A, Srinivasamani A, Holzhauer S, Riese MJ, Zheng Y, Wang D, Burns R, Reimer MH, Rao S, Lemke A, Tsaih SW, Flister MJ, Lao S, Dahl R, Thakar MS, et al. Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells. Cancer Immunology Research. PMID 31515257 DOI: 10.1158/2326-6066.Cir-18-0934  0.302
2019 Flister MJ, Joshi A, Bergom C, Rui H. Mapping Mammary Tumor Traits in the Rat. Methods in Molecular Biology (Clifton, N.J.). 2018: 249-267. PMID 31228161 DOI: 10.1007/978-1-4939-9581-3_12  0.434
2019 Wright KD, Miller BS, El-Meanawy S, Tsaih SW, Banerjee A, Geurts AM, Sheinin Y, Sun Y, Kalyanaraman B, Rui H, Flister MJ, Sorokin A. The p52 isoform of SHC1 is a key driver of breast cancer initiation. Breast Cancer Research : Bcr. 21: 74. PMID 31202267 DOI: 10.1186/S13058-019-1155-7  0.364
2019 Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, ... ... Flister MJ, et al. Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. Breast Cancer Research and Treatment. PMID 31165373 DOI: 10.1007/S10549-019-05307-8  0.557
2019 Plasterer C, Tsaih SW, Lemke A, Schilling R, Dwinell M, Rau A, Auer P, Rui H, Flister MJ. Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients. G3 (Bethesda, Md.). PMID 30914425 DOI: 10.1534/G3.118.200873  0.406
2019 Schlaak RA, Frei A, Schottstaedt AM, Tsaih SW, Fish BL, Harmann L, Liu Q, Gasperetti T, Medhora MM, North PE, Strande JL, Sun Y, Rui H, Flister MJ, Bergom C. Mapping Genetic Modifiers of Radiation-Induced Cardiotoxicity to Rat Chromosome 3. American Journal of Physiology. Heart and Circulatory Physiology. PMID 30848680 DOI: 10.1152/Ajpheart.00482.2018  0.323
2019 Rau A, Flister M, Rui H, Auer PL. Exploring drivers of gene expression in the Cancer Genome Atlas. Bioinformatics (Oxford, England). 35: 62-68. PMID 30561551 DOI: 10.1093/Bioinformatics/Bty551  0.376
2018 Pan J, Lee Y, Cheng G, Zielonka J, Zhang Q, Bajzikova M, Xiong D, Tsaih SW, Hardy M, Flister M, Olsen CM, Wang Y, Vang O, Neuzil J, Myers CR, et al. Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity. Iscience. 3: 192-207. PMID 30428319 DOI: 10.1016/J.Isci.2018.04.013  0.332
2018 Jagtap J, Sharma G, Parchur AK, Gogineni V, Bergom C, White S, Flister MJ, Joshi A. Erratum: Methods for detecting host genetic modifiers of tumor vascular function using dynamic near-infrared fluorescence imaging: errata. Biomedical Optics Express. 9: 2543. PMID 30258671 DOI: 10.1364/Boe.9.002543  0.337
2018 Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo J, Bibbo M, ... ... Flister MJ, et al. Loss of nuclear localized Parathyroid Hormone-related Protein in primary breast cancer predicts poor clinical outcome and correlates with suppressed Stat5 signaling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30097435 DOI: 10.1158/1078-0432.Ccr-17-3280  0.385
2018 Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A. Vascular Interventional Radiology Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods. Acs Nano. PMID 29969226 DOI: 10.1021/Acsnano.8B01424  0.317
2018 Flister MJ, Bergom C. Genetic Modifiers of the Breast Tumor Microenvironment. Trends in Cancer. 4: 429-444. PMID 29860987 DOI: 10.1016/J.Trecan.2018.04.003  0.396
2018 Bergom C, Schlaak R, Frei A, Fish B, Harmann L, Gasperetti T, Schottstaedt A, Flister M, Medhora M, Strande J. Abstract P2-11-18: The use of consomic animal models to identify genetic factors that modulate radiation-induced cardiac toxicity Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-11-18  0.404
2018 Schlaak RA, Frei A, Schottstaedt AM, Fish BL, Harmann L, Gasperetti T, Flister MJ, Medhora M, Strande JL, Bergom CR. Abstract 4165: Novel genetic rat models to identify factors that modulate cardiac and tumor radiation sensitivity Tumor Biology. DOI: 10.1158/1538-7445.Am2018-4165  0.375
2018 Plasterer C, Lemke A, Murphy D, Bergom C, Joshi A, Rui H, Flister MJ. Abstract 408: Evidence of DLL4, NNAT, and SLC35C2 in suppression of breast cancer initiation, growth, and metastasis Cancer Research. 78: 408-408. DOI: 10.1158/1538-7445.Am2018-408  0.442
2018 Bergom C, Schlaak RA, Frei A, Schottstaedt AM, Mascari CA, Fish B, Harmann L, Gasperetti T, Strande JL, Medhora M, Flister MJ. Consomic Rat Models Identify Genetic Factors that Modulate Radiation-Induced Cardiac Toxicity and Inflammation International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.642  0.32
2018 Schottstaedt AM, Schlaak R, Frei A, Fish B, Harmann L, Gasperetti T, Flister MJ, Medhora M, Strande JL, Bergom C. (P06) Identifying Genetic Factors Influencing Radiation-Induced Cardiac Toxicity Using Novel Genetic Rat Models International Journal of Radiation Oncology*Biology*Physics. 101: E23. DOI: 10.1016/J.Ijrobp.2018.02.094  0.325
2017 Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, et al. Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. Breast Cancer Research and Treatment. PMID 28567545 DOI: 10.1007/S10549-017-4311-8  0.634
2017 Flister M, Plasterer C, Tsaih S, Lemke A, Murphy D, Joshi A, LaViolette P, Bergom C. Abstract 782: Revisiting the angiogenic switch: Host genetic modifiers induce non-productive angiogenesis and inhibit breast cancer Cancer Research. 77: 782-782. DOI: 10.1158/1538-7445.Am2017-782  0.389
2017 Straza MW, Rymaszewski A, Nickel KP, Frei A, Chatterjee A, Schlaak R, Joshi A, Flister M, Kimple RJ, Bergom C. Abstract 5898: The consomic xenograft model identifies genetic changes in the tumor microenvironment that alter the growth and metastasis of head and neck cancers Cancer Research. 77: 5898-5898. DOI: 10.1158/1538-7445.Am2017-5898  0.403
2016 Bergom C, Straza M, Rymaszewski A, Frei A, Lemke A, Tsaih S, Jacob H, Flister MJ. Abstract B07: Utilizing consomic xenograft models to identify genetic variants in the tumor microenvironment that determine breast cancer radiation responses Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B07  0.475
2016 Straza MW, Rymaszewski A, Frei A, Lemke A, Tsaih SW, Flister M, Bergom C. A Novel Breast Cancer Xenograft Model Identifies Genetic Variants in the Tumor Microenvironment that Enhance Radiation Responses International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.196  0.444
2015 Flister MJ, Stoddard A, Tsaih S, Lemke A, Lazar J, Jacob H. Abstract PR16: New tools for mapping genetic modifiers of cancer risk in the tumor microenvironment Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr16  0.46
2015 Flister MJ, Stoddard A, Tsaih S, Lemke A, Lazar J, Jacob H. Abstract PR08: New tools for mapping genetic modifiers of cancer risk in the tumor microenvironment Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr08  0.46
2015 Flister M, Lemke A, Dwinell M, Bergom C, Shull J, Jacob H. Abstract 3217: NextGen strategies for mapping genetic modifiers in the tumor microenvironment Cancer Research. 75: 3217-3217. DOI: 10.1158/1538-7445.Am2015-3217  0.459
2014 Prisco SZ, Priestley JR, Weinberg BD, Prisco AR, Hoffman MJ, Jacob HJ, Flister MJ, Lombard JH, Lazar J. Vascular dysfunction precedes hypertension associated with a blood pressure locus on rat chromosome 12. American Journal of Physiology. Heart and Circulatory Physiology. 307: H1103-10. PMID 25320330 DOI: 10.1152/Ajpheart.00464.2014  0.34
2014 Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, et al. CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. Cancer Research. 74: 6419-29. PMID 25172839 DOI: 10.1158/0008-5472.Can-13-3212  0.64
2012 Hall KL, Volk-Draper LD, Flister MJ, Ran S. New model of macrophage acquisition of the lymphatic endothelial phenotype. Plos One. 7: e31794. PMID 22396739 DOI: 10.1371/Journal.Pone.0031794  0.568
2012 Volk-Draper L, Hall K, Flister M, Ran S. Abstract 400: A new model for macrophage transdifferentiation into lymphatic endothelial cell progenitors Cancer Research. 72: 400-400. DOI: 10.1158/1538-7445.Am2012-400  0.596
2011 Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S. Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases. Neoplasia (New York, N.Y.). 13: 327-38. PMID 21472137 DOI: 10.1593/Neo.101490  0.644
2011 Flister MJ, Volk LD, Ran S. Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB. Microcirculation (New York, N.Y. : 1994). 18: 85-101. PMID 21166921 DOI: 10.1111/J.1549-8719.2010.00057.X  0.542
2010 Ran S, Volk L, Hall K, Flister MJ. Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology : the Official Journal of the International Society For Pathophysiology / Isp. 17: 229-51. PMID 20036110 DOI: 10.1016/J.Pathophys.2009.11.003  0.64
2010 Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood. 115: 418-29. PMID 19901262 DOI: 10.1182/Blood-2008-12-196840  0.57
2010 Flister MJ, Hall KL, Wilber A, Ran S. Abstract 3442: Inflammatory mediators activate lymphatic endothelial cells (LECs) through elevation of NF-κB, Prox1, and VEGFR-3 Cancer Research. 70: 3442-3442. DOI: 10.1158/1538-7445.Am10-3442  0.589
2010 Hall K, Flister M, Volk L, Curry S, Wilber A, Ran S. Abstract 2354: Angiopoietin-2 role in breast cancer metastasis Cancer Research. 70: 2354-2354. DOI: 10.1158/1538-7445.Am10-2354  0.642
2009 Volk L, Stutzman A, Flister M, Hall K, Chihade D, Desai N, Trieu V, Ran S. Mechanisms ofnab-paclitaxel and bevacizumab cooperation in inhibition of breast tumor growth and metastasis. Cancer Research. 69: 1032. DOI: 10.1158/0008-5472.Sabcs-1032  0.629
2008 Volk LD, Flister MJ, Bivens CM, Stutzman A, Desai N, Trieu V, Ran S. Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy. Neoplasia (New York, N.Y.). 10: 613-23. PMID 18516298 DOI: 10.1593/Neo.08302  0.632
2007 Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. International Journal of Cancer. Journal International Du Cancer. 121: 2181-91. PMID 17597103 DOI: 10.1002/Ijc.22937  0.631
2006 Whitehurst B, Eversgerd C, Flister M, Bivens CM, Pickett B, Zawieja DC, Ran S. Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture. Lymphatic Research and Biology. 4: 119-42. PMID 17034293 DOI: 10.1089/Lrb.2006.4.119  0.582
Show low-probability matches.